Speech-Language Pathologists in Newington, CT Accepting Medicare

15 Speech-Language Pathologists found. Showing 1 - 15

Karli Andrews, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1268 Main St Ste 204, Newington, CT 06111 Phone: 860-200-7450

Linda Salamone, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 181 Patricia Genova Drive, 5th Floor Eastern Rehabilitation Network, Newington, CT 06111 Phone: 860-667-5480    Fax: 860-667-8416

Sylvia Reis-fisher, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 181 Patricia Genova Drive, Eastern Rehabilitation Network 5th Floor, Newington, CT 06111 Phone: 860-667-5449    Fax: 860-667-8416

Elise T Suchocki, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 137 Tremont St, Newington, CT 06111 Phone: 860-989-4389

Mrs. Kristin E'lise Parenteau Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 256 New Britain Ave, Newington, CT 06111 Phone: 860-666-5689

Pediatric Communication Center, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1268 Main St, Newington, CT 06111 Phone: 860-216-1100

Mattie Hulett, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1268 Main St Ste 204, Newington, CT 06111 Phone: 860-216-1100

Aileen Panarella, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 181 Patricia Genova Drive, Eastern Rehabilitation Network (5th Floor), Newington, CT 06111 Phone: 860-667-5480    Fax: 860-667-8416

Mrs. Jennifer Lyn Sakowicz, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1268 Main St Ste 204, Newington, CT 06111 Phone: 860-216-1100

Heather Demers, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 67 Chapman St, Newington, CT 06111 Phone: 860-798-8409

Melanie Wagner, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 256 New Britain Ave, Newington, CT 06111 Phone: 860-666-5689    Fax: 860-666-2086

Ashley Zapata, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 181 Patricia Genova Drive, Eastern Rehabilitation Network (5th Floor), Newington, CT 06111 Phone: 860-667-5480    Fax: 860-667-8416

Kimberly Rose Ramos Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 225 Hartford Ave, Newington, CT 06111 Phone: 860-801-0960

Nicole Williams Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1268 Main St, Newington, CT 06111 Phone: 860-200-7450

Rachel Gravel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1268 Main St, Suite 204, Newington, CT 06111 Phone: 860-216-1100

News Archive

Cancer cure worth $50 trillion

A new study, to be published in a forthcoming issue of the Journal of Political Economy, calculates the prospective gains that could be obtained from further progress against major diseases.

New advice on anti-inflammatory drugs called Cox-2 Inhibitors, including Celebrex

Patients who are taking Celebrex, Bextra and Arcoxia should make a non-urgent appointment with their GP to review their treatment. Patients who have established heart disease or who are at high risk of stroke will have their treatment changed.

Researchers report first-ever link between noradrenergic neurons and vulnerability to depression

The team of Bruno Giros, a researcher at the Douglas Mental Health University Institute and professor of psychiatry at McGill University, reports the first-ever connection between noradrenergic neurons and vulnerability to depression. Published in the journal Nature Neuroscience, this breakthrough paves the way for new depression treatments that target the adrenergic system.

Two Phase I studies of Stedivaze demonstrate safety in patients with asthma and COPD

Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).

Read more Medical News

› Verified 6 days ago